EU-Arzneimittelbehörde empfiehlt Remdesivir-Zulassung für Covid-19-Behandlung

SHOTLIST HAMBURG, DEUTSCHLAND8. APRIL 2020QUELLE: POOL1. Foto Vials of the drug Remdesivir lie during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic.HAMBURG, DEUTSCHLAND8. APRIL 2020QUELLE: POOLEINSCHRÄNKUNGEN: NICHT ZU VERWENDEN NACH: 29. MAI 2020 14:44:14 GMT2. Foto One vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic.HAMBURG, DEUTSCHLAND8. APRIL 2020QUELLE: POOL3. Foto One vial of the drug Remdesivir lies during a press conference about the start of a study with the Ebola drug Remdesivir in particularly severely ill patients at the University Hospital Eppendorf (UKE) in Hamburg, northern Germany on April 8, 2020, amidst the new coronavirus COVID-19 pandemic.FOSTER CITY, VEREINIGTE STAATEN30. APRIL 2020QUELLE: AFPTV4. Halbnahe Gilead sign5. Nah Gilead logo